Surfactant as a drug carrier
Drug delivery using a surfactant vehicle has the potential to prevent systemic side effects by delivering therapeutic agents directly to the respiratory system. The inherent chemical properties of surfactant allows it to readily distribute throughout the respiratory system. Therapeutic agents delive...
Main Authors: | Sett, A, Roehr, CC, Manley, BJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2023
|
Similar Items
Similar Items
-
Can pathophysiological lung function markers guide the use of postnatal corticosteroids for bronchopulmonary dysplasia?
by: Kwok, TC, et al.
Published: (2024) -
Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
by: Ramaswamy, VV, et al.
Published: (2021) -
To sedate or not to sedate for less invasive surfactant administration: an ethical approach
by: Peterson, J, et al.
Published: (2021) -
Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
by: Ramaswamy, VV, et al.
Published: (2021) -
Pulmonary Surfactant and Drug Delivery: An Interface-Assisted Carrier to Deliver Surfactant Protein SP-D Into the Airways
by: Cristina García-Mouton, et al.
Published: (2021-01-01)